Emmaus Life Sciences Receives Endari® Marketing Authorization from the Bahrain NHRA

Stock Information for Emmaus Life Sciences Incorporation

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Emmaus Life Sciences Incorporation

Emmaus Life Sciences Reports Quarterly Financial Results
Emmaus Life Sciences Announces Willis C. Lee as Chief Executive Officer
Emmaus Life Sciences Announces Outcome of FDA Inspection of Postmarketing Adverse Drug Experience Compliance Program
Emmaus Life Sciences Reports 2023 Financial Results
Emmaus Life Sciences Reports Delayed Filing of Annual Report
Emmaus Life Sciences Receives Marketing Authorization for Puerto Rico
Emmaus Life Sciences Reports Q3 2023 Financial Results
Emmaus Life Sciences Reports Management Changes

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.